Sands Capital Ventures »

Rayzebio shares owned by Sands Capital Ventures

Quarter-by-quarter ownership of Rayzebio shares owned by Sands Capital Ventures from 13F filings

Historical chart of Sands Capital Ventures investment in Rayzebio

Tip: Access up to 7 years of quarterly data

All positions including Rayzebio held by Sands Capital Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rayzebio by Sands Capital Ventures

Quarter filed Position value Share count Share price at filing
2023-09-30 $27M 1.2M 22.20

More positions owned by Sands Capital Ventures

Nu Hldgs Ord Shs Cl A (NU)
Uipath Cl A (PATH)
Doordash Cl A (DASH)
Snowflake Cl A (SNOW)
Rayzebio
Samsara Com Cl A (IOT)
10x Genomics Cl A Com (TXG)
Klaviyo Class A Com (KVYO)
Acrivon Therapeutics Common Stock (ACRV)
Acumen Pharmaceuticals (ABOS)
Olink Hldg Ab Sponsored Ads (OLK)
Tarsus Pharmaceuticals (TARS)
Taysha Gene Therapies Com Shs (TSHA)
Spruce Biosciences (SPRB)
908 Devices (MASS)

View all positions for Sands Capital Ventures

Top funds holding Rayzebio

Viking Global Investors
venBio Partners
Versant Venture Management
VR Adviser
Wellington Management Company
OrbiMed Advisors
Redmile Group
Samsara BioCapital
Fairmount Funds Management
Cormorant Asset Management
Vanguard Group
Hillhouse Capital Advisors
Deerfield Management Company
Alliancebernstein
Laurion Capital Management

View all funds holding Rayzebio